Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heart Sense is a private Polish medical device company developing an epicardial ECG monitoring probe for use during beating-heart cardiac surgery, especially off-pump coronary artery bypass grafting. Its core product is designed to record electrocardiographic signals directly from the heart surface when standard monitoring may be lost or distorted during surgical manipulation. The company positions the device as a compatibility-friendly solution that can work with standard certified cardiomonitors rather than requiring a dedicated monitoring platform. Heart Sense appears to be an early-stage medtech company with patent activity, pre-seed backing, and a focus on improving intraoperative safety in cardiac surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heart Sense.